BEMER therapy can be used to improve the circulation and to give general support to the body’s self-regulatory mechanisms. Through the following scientifically proven effects, BEMER therapy can lead to the improvement or stabilisation of physical well-being and can contribute significantly to the complementary treatment of multiple sclerosis:
- Positive physiological effect on the condition of microcirculation, and increased utilisation of oxygen in the capillary tissue
- Positive effect on the protein biosynthesis (repair proteins)
- Improved micro-hemodynamic conditions for the first steps of immunological processes, and thereby in indirect strengthening of the body’s own defense mechanisms
- Positive effect on the vegetative nervous system
- Through the activation of metabolism, oxygenation, and circulation the all over physical and psychological health can be positively influenced.
- The increased blood flow in the muscle tissues is an essential effect for paralysis and spasms.
- The immune system can be regulated and stabilised by the BEMER impulse, leading to a reduction of inflammatory and autoimmune-allergic reactions.
- Individual studies suggest that frequency and severity of the relapses can be reduced with long-term therapy, and the course of the illness can be milder.
- Melatonin production is regulated resulting in better sleep, less depression and improved cell regeneration
BEMER therapy is a complex method that optimises energy production by the individual cells (ATP) through improved circulation and increased oxygen utilisation, thereby contributing to the overall regulation of the body’s metabolism. It is therefore an important and essential foundation for strengthening the body’s self-healing mechanisms, supporting other treatment measures in the environment of a holistic approach, and increases effectiveness of clinical treatment concepts.
A European physician’s user study under the direction of the AFB documented the effects of the electromagnetic field of the BEMER therapy system. A total of 1116 patient protocols were captured. Since several patients presented with more than one clinical condition, 2031 cases of illness were documented. A therapy span of 8 weeks and observation of 14 / 223 subjects showed the results listed below.
Individual observations suggested that the amount and severity of relapses decreased with long-term therapy, and that the all-over health improved.
NB: is it important to note that as BEMER therapy is continued over time , the ‘no change’ percentages decrease and the ’complaint free’ percentages increase.
Test conducted by: Center for Sports Medicine in Tarnobrzeg, VR Poland Witold Furgal, M.D., Head of the Center for Sports Medicine
Timing: December 1999 through February 2000
Subjects: Twenty-one patients with varying illnesses. In addition, the BEMER was used with 15 athletes as an element of biological regeneration.
Findings:
During an initial walking test of the MS patients, the maximum achievement was 30 meters (threshold of fatigue). The movement speed was measured on an electric treadmill (Jaeger), and the subjects were able to handle a speed of 2,5 to 4 km/hr. After 20 therapies with the BEMER (one per day – more was not possible due to transportation constraints), the patients were able to walk an average of 400 meters on the treadmill at the same speed. One patient (40 years old), who needed to be transported by bus at the beginning of the therapy, was able to walk the distance from her home to the sports center (2km) after one month, and also was able to perform household chores on her own again.
Information about Multiple Sclerosis
Multiple sclerosis is one of the most prevalent diseases of the nervous system that can affect all areas of the central nervous system and the spinal cord. It is characterized by tissue damages in the coating (myelin sheath) of certain nerve fibers. The circular lesions (demyelination) in the walls of the myelin sheath lead to disturbances in nerve conductivity.
This results in a number of neurological deficits that vary depending on the affected areas. Occurrence of the disease peaks between the age of 20 and 40, and women are affected more often than men. One remarkable fact is that MS is more prevalent in cold or moderate climates than in warmer regions. About 80% of those affected display the characteristic course of the disease in exacerbations or relapses that can develop over the course of days to several weeks, and then subside. Usually after a relapse some more or less pronounced disorders remain. About 20% of the time MS appears in the more slowly developing chronic progressive form. In both cases, the progression of the disease can be spread out over decades.
The symptoms can be many-fold and often are not all that characteristic. Initially there may be vision disturbances like double vision or blurred vision. In subsequent stages there can be partial or complete paralysis of the arms and legs, changes in skin sensation, bladder and bowel difficulties, problems with coordination and balance, as well as changes in speech so that it sounds drawn out, with incorrect syllables being emphasized, or with outburst-like pronunciation.
Although many risk factors for multiple sclerosis have been identified, no definitive cause has been found. MS likely occurs as a result of some combination of both environmental and genetic factors. Various theories try to combine the known data into plausible explanations. Although most accept an autoimmune explanation, several theories suggest that MS is an appropriate immune response to one or several underlying conditions like viral infections, toxic environment, etc. MS patients frequently show an increased level of mercury in their bodies as well as other toxic substances.
Due to the wide variety of physical and mental symptoms, diagnosis is often prolonged and can take several years. Generally, the recurring relapses become apparent and the attending physician will try to reconstruct the progress of the disease. Some of the clinical tests available are lumbar puncture to collect and test cerebrospinal fluid, MRI to show lesions (demyelinations), and tests that measure the speed of nerve conductivity.
